Eli Lilly has unveiled a new program aimed at making its weight-loss drug, Zepbound, more accessible to self-pay patients by offering it at...
By 193cc Agency CouncilAugust 28, 2024The Federal Trade Commission (FTC) has raised concerns over the potential inflation of drug prices, specifically highlighting the impact on medications like Novo...
By 193cc Agency CouncilMay 1, 2024